Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»Two Drugs – Already FDA-Approved for Other Illnesses – Show Promise Against COVID-19
    Health

    Two Drugs – Already FDA-Approved for Other Illnesses – Show Promise Against COVID-19

    By American Society for MicrobiologyMay 5, 2020No Comments2 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Stylized Novel Coronavirus SARS-CoV-2
    Korean researchers tested 48 FDA-approved drugs against SARS-CoV-2 and found two promising ones already approved for other illnesses. Approval for other uses would speed up their use for COVID-19.

    Korean researchers have screened 48 FDA-approved drugs against SARS-CoV-2, and found that two, that are already FDA-approved for other illnesses, seem promising. The FDA approval for other uses would greatly reduce the time needed to gain FDA approval of use in COVID-19. The research is published in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.

    The investigators tested the drugs in Vero cells, a cell line developed from kidney cells of the African Green Monkey, which are commonly used to grow viruses for vaccine production.

    An anti-helminthic drug called niclosamide demonstrated “very potent” antiviral activity against SARS-CoV-2, according to coauthors Sangeun Jeon, Meehyun Ko, and their collaborators, of the Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam, Korea. “Not surprisingly, its broad-spectrum antiviral effect has been well documented in the literature, including antiviral properties against SARS- and MERS-CoV,” they write.

    A downside of niclosamide is low absorption, which undercuts the drug’s power by reducing the dose that reaches the target tissue. However, “Further development or drug formulation could enable an effective delivery of this drug to the target tissue,” according to the report.

    Despite substantially lower antiviral potency, ciclesonide, an inhaled corticosteroid used to treat asthma and allergic rhinitis, also showed promise against SARS-CoV-2. Intriguingly, the investigators note that a study published earlier this year ( by Matsuyama et al.) a treatment report of 3 patients infected by SARS-CoV-2, demonstrated antiviral activity and revealed the drug’s molecular target to be a viral protein called Nsp15.

    “With its proven anti-inflammatory activity, ciclesonide may represent as a potent drug which can manifest [the] dual roles [of antiviral and anti-inflammatory] for the control of SARS-CoV-2 infection,” the investigators conclude. The anti-inflammatory activity might play a critical role in dampening or preventing the cytokine storms, an immune inflammatory overreaction that can kill COVID-19 patients.

    Reference: “Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs” by Sangeun Jeon, Meehyun Ko, Jihye Lee, Inhee Choi, Soo Young Byun, Soonju Park, David Shum, Seungtaek Kim, 4 May 2020, Antimicrobial Agents and Chemotherapy.
    DOI: 10.1128/AAC.00819-20

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    American Society for Microbiology COVID-19 Microbiology Virology
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    Potential Causes of Increased Transmission in COVID-19 Variants

    MMR Vaccine Could Protect Against the Worst COVID-19 Symptoms – “A Low-Risk-High-Reward Preventive Measure”

    Severity of COVID-19 May Depend on Your Individual Genetic Variation in Immune System

    Promising MERS Vaccine Candidate Might Be Able to Block Coronavirus Infections

    Coronavirus Fight: Scientists Identify COVID-19 Drug That “Kills” the Virus Within 48 Hours

    Northwestern Medicine Launches COVID-19 Drug Trial

    Single Mutation Could Significantly Enhance Wuhan Coronavirus

    Strains of Coronavirus 2019-nCoV Detected in France Isolated

    Tracking Dangerous Bat Coronaviruses With Next-Generation DNA Sequencing

    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Ancient Tomb Reveals That People Were Getting High on Cannabis 2,800 Years Ago

    Scientists Discover New Form of Prostate Cancer

    Mars May Not Be Dead After All, New Discovery Suggests

    A Tiny Region Deep Inside Your Brain Helps Decide What You Remember

    Scientists Develop a Groundbreaking Rechargeable Battery That Runs on Vitamin B12

    Scientists Discover a Hidden Immune System Difference That Could Explain Why Obesity Affects Men and Women Differently

    More Than a Billion Years of Earth’s History Is Missing – Scientists May Finally Know Why

    Popular Weight-Loss Drugs May Have a Surprising Effect on Your Brain

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Chemists Weave Molecules Into a Powerful New Material That Traps Toxic Chemicals
    • Scientists Unlock a New Way To Photograph Events That Vanish in Trillionths of a Second
    • A 120-Year-Old Gap in Einstein’s Physics May Hold the Key to the Universe’s Earliest Matter
    • Scientists Discover That Immune Cells May Be Secretly Helping Pancreatic Cancer Hide
    • Why Do We Feel Colder As We Get Older? New Study Uncovers a Hidden Mechanism
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.